PLIANT THERAPEUTICS, INC.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2020 | $-12.8M | $-13.1M | $336.0K | $425.0K |
| Jun 2020 | $7.8M | $7.5M | $286.0K | $786.0K |
| Sep 2020 | $-15.8M | $-16.1M | $323.0K | $1.2M |
| Dec 2020 | $-16.5M | $-17.1M | $587.0K | $1.5M |
| Mar 2021 | $-13.7M | $-13.9M | $242.0K | $2.6M |
| Jun 2021 | $-19.4M | $-20.0M | $639.0K | $2.3M |
| Sep 2021 | $-22.5M | $-23.0M | $480.0K | $2.8M |
| Dec 2021 | $-19.9M | $-20.5M | $592.0K | $2.8M |
| Mar 2022 | $-20.5M | $-21.1M | $644.0K | $3.5M |
| Jun 2022 | $-24.4M | $-24.7M | $254.0K | $3.4M |
| Sep 2022 | $-18.5M | $-19.2M | $696.0K | $4.8M |
| Dec 2022 | $-31.2M | $-31.4M | $166.0K | $10.9M |
| Mar 2023 | $-30.3M | $-30.4M | $163.0K | $11.9M |
| Jun 2023 | $-24.8M | $-25.4M | $603.0K | $13.0M |
| Sep 2023 | $-36.2M | $-36.3M | $94.0K | $10.4M |
| Dec 2023 | $-25.1M | $-25.2M | $61.0K | $9.2M |
| Mar 2024 | $-30.3M | $-31.8M | $1.5M | $9.7M |
| Jun 2024 | $-45.3M | $-46.5M | $1.3M | $10.6M |
| Sep 2024 | $-32.3M | $-33.2M | $896.0K | $8.9M |
| Dec 2024 | $-47.7M | $-47.9M | $209.0K | $8.4M |
| Mar 2025 | $-48.9M | $-49.1M | $262.0K | $8.9M |
| Jun 2025 | $-40.6M | $-40.7M | $112.0K | $6.4M |
| Sep 2025 | $-21.1M | $-21.1M | $0 | $6.4M |
| Dec 2025 | $-17.8M | $-17.8M | $0 | $4.5M |
| Mar 2026 | $-19.2M | $-19.2M | $0 | $4.3M |
| Jun 2026 | $-12.8M | $-12.8M | $0 | $4.2M |